Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Dec 2023 for Seelos Therapeutics, INC..
Insider track record
Disclosed buys
3
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-22.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Raj Mehra: trading record in brief
This profile gathers the share dealings of Raj Mehra in Seelos Therapeutics, Inc. In total, 4 filings cover trades dated from 24 January 2019 to 1 December 2023.
No open-market sale appears; the market trades are 3 purchases worth €235k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant. 2023 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €92k.
The latest filing, published on 1 December 2023, reports an open-market purchase of €92k in Seelos Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Raj Mehra
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
75,757 shares@ €1.211964.1% of flowCommon StockSEC:0001104659-23-122840:0
Canonical exit: 29 Feb 2024 (T+90)
66,667 shares@ €0.7735.9% of flowCommon StockSEC:0001136261-22-000159:0
Canonical exit: 29 Jun 2022 (T+90)
2 of 2 declarations
